САЩ - английски - NLM (National Library of Medicine)

otsuka america pharmaceutical, inc. - aripiprazole (unii: 82vfr53i78) (aripiprazole - unii:82vfr53i78) - aripiprazole 2 mg - abilify (aripiprazole) oral tablets, orally-disintegrating tablets, and oral solution are indicated for the treatment of: - schizophrenia - acute treatment of manic and mixed episodes associated with bipolar i disorder - adjunctive treatment of major depressive disorder - irritability associated with autistic disorder - treatment of tourette's disorder abilify injection is indicated for the treatment of: - agitation associated with schizophrenia or bipolar mania abilify is contraindicated in patients with a history of a hypersensitivity reaction to aripiprazole. reactions have ranged from pruritus/urticaria to anaphylaxis [see adverse reactions (6.2)] . pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to atypical antipsychotics, including abilify, during pregnancy. healthcare providers are encouraged to register patients by contacting the national pregnancy registry for atypical antipsychotics at 1-866-961-2388 or visit http://womensmentalhea

Нова Зеландия - английски - Medsafe (Medicines Safety Authority)

amo australia pty limited (nz) - benzalkonium chloride 0.004%; disodium edetate dihydrate 0.0127%; polyvinyl alcohol 2.5% - contact lens solution - active: benzalkonium chloride 0.004% disodium edetate dihydrate 0.0127% polyvinyl alcohol 2.5% excipient: dibasic sodium phosphate heptahydrate glucose hydrochloric acid hypromellose monobasic sodium phosphate monohydrate potassium chloride purified water sodium chloride sodium hydroxide

Нова Зеландия - английски - Medsafe (Medicines Safety Authority)

smith & nephew ltd - benzalkonium chloride 0.004%{relative} (0.008% as 50% solution); disodium edetate dihydrate 0.02%{relative};  ; polyvinyl alcohol 1.4%{relative} - eye drops, solution - 0.004%/0.02%/1.4% - active: benzalkonium chloride 0.004%{relative} (0.008% as 50% solution) disodium edetate dihydrate 0.02%{relative}   polyvinyl alcohol 1.4%{relative} excipient: hyetellose purified water sodium chloride sodium hydroxide

Нова Зеландия - английски - Medsafe (Medicines Safety Authority)

smith & nephew ltd - benzalkonium chloride 0.004%{relative}; disodium edetate dihydrate 0.02%{relative};   - contact lens solution - active: benzalkonium chloride 0.004%{relative} disodium edetate dihydrate 0.02%{relative}  

Ирландия - английски - HPRA (Health Products Regulatory Authority)

optrex limited - naphazoline hydrochloride; hamamelis water - eye drops, solution - 12.5/0.01 percent weight/volume - sympathomimetics used as decongestants; naphazoline, combinations

Австралия - английски - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - pemetrexed disodium -

Австралия - английски - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - pemetrexed disodium, quantity: 1102.8 mg (equivalent: pemetrexed, qty 1000 mg) - injection, powder for - excipient ingredients: mannitol; sodium hydroxide; hydrochloric acid - malignant pleural mesothelioma pemetrexed sun, in combination with cisplatin, is indicated for the treatment of patients with malignant pleural mesothelioma.,non-small cell lung cancer pemetrexed sun in combination with cisplatin is indicated for initial treatment of patients with locally advance or metastatic non-small cell lung cancer other than predominantly squamous cell histology. pemetrexed sun as monotherapy is indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology after prior platinum-based chemotherapy.

Австралия - английски - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - pemetrexed disodium, quantity: 551.4 mg (equivalent: pemetrexed, qty 500 mg) - injection, powder for - excipient ingredients: mannitol; sodium hydroxide; hydrochloric acid - malignant pleural mesothelioma pemetrexed sun, in combination with cisplatin, is indicated for the treatment of patients with malignant pleural mesothelioma.,non-small cell lung cancer pemetrexed sun in combination with cisplatin is indicated for initial treatment of patients with locally advance or metastatic non-small cell lung cancer other than predominantly squamous cell histology. pemetrexed sun as monotherapy is indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology after prior platinum-based chemotherapy.

Австралия - английски - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - pemetrexed disodium, quantity: 110.28 mg (equivalent: pemetrexed, qty 100 mg) - injection, powder for - excipient ingredients: mannitol; sodium hydroxide; hydrochloric acid - malignant pleural mesothelioma pemetrexed sun, in combination with cisplatin, is indicated for the treatment of patients with malignant pleural mesothelioma.,non-small cell lung cancer pemetrexed sun in combination with cisplatin is indicated for initial treatment of patients with locally advance or metastatic non-small cell lung cancer other than predominantly squamous cell histology. pemetrexed sun as monotherapy is indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology after prior platinum-based chemotherapy.

Австралия - английски - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - pemetrexed disodium hemipentahydrate -